Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

GALTGALT
20 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in GALECTIN THERAPEUTICS INC

Bank of New York Mellon Corp holds 105,742 shares of GALT (GALECTIN THERAPEUTICS INC), worth $490,644 as of 2026-Q2. This is a new position. GALT represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$490,644

Current Shares

105,742

Total Value Change

+$249,644

Total Shares Change

-1,668

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
105,742
-
$490,6440.0%$4.64
33
2025-Q2
Exited
0
-100.0%
$00.0%$2.33
0
2025-Q1
Unchanged
50,826
0.0%
$62,0070.0%$1.52
0
2024-Q4
Increased
50,826
+19.0%
$65,5650.0%$1.10
17
2024-Q3
Decreased
42,721
-33.7%
$117,4830.0%$2.71
0
2024-Q2
New
64,423
-
$145,5950.0%$2.26
34
2024-Q1
Exited
0
-100.0%
$00.0%$2.39
0
2023-Q4
Unchanged
23,080
0.0%
$38,3130.0%$1.66
0
2023-Q3
Unchanged
23,080
0.0%
$44,3130.0%$1.92
0
2023-Q2
Increased
23,080
0.0%
$33,2350.0%$1.39
13
2023-Q1
Unchanged
23,079
0.0%
$48,4660.0%$2.17
0
2022-Q4
Unchanged
23,079
0.0%
$26,0790.0%$1.13
0
2022-Q3
Unchanged
23,079
0.0%
$38,0000.0%$1.65
0
2022-Q2
Unchanged
23,079
0.0%
$30,0000.0%$1.25
0
2022-Q1
Unchanged
23,079
0.0%
$37,0000.0%$1.71
0
2021-Q4
Unchanged
23,079
0.0%
$48,0000.0%$2.11
0
2021-Q3
Decreased
23,079
0.0%
$90,0000.0%$3.82
0
2021-Q2
Decreased
23,080
-76.9%
$74,0000.0%$3.45
0
2021-Q1
Decreased
99,901
-7.0%
$216,0000.0%$2.03
0
2020-Q4
New
107,410
-
$241,0000.0%$2.30
32

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used